Mark Austin
Director of Finance/CFO at PERSPECTIVE THERAPEUTICS, INC.
Net worth: 99 996 $ as of 2024-03-30
Profile
Mark J.
Austin is currently working as the Co-CFO, Secretary, CAO, VP & Controller at Perspective Therapeutics, Inc. He previously worked as the Chief Financial & Accounting Officer at IsoRay, Inc. from 2017 to 2018.
Prior to that, he held the position of Manager & Senior Associate at KPMG Advisory Sp zoo Spolka Komandytowa from 2009 to 2017.
Mr. Austin completed his undergraduate degree at Santa Clara University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-22 | 84,030 ( 0.01% ) | 99 996 $ | 2024-03-30 |
Mark Austin active positions
| Companies | Position | Start |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Director of Finance/CFO | 2017-06-30 |
Former positions of Mark Austin
| Companies | Position | End |
|---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The private company is based in Warsaw, Poland. | Corporate Officer/Principal | 2017-06-30 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Director of Finance/CFO | - |
Training of Mark Austin
| Santa Clara University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The private company is based in Warsaw, Poland. | Finance |
| Perspective Therapeutics, Inc. |
- Stock Market
- Insiders
- Mark Austin